FATTIZZO, BRUNO
FATTIZZO, BRUNO
Dipartimento di Oncologia ed Emato-Oncologia
Autoimmune hemolytic anemia: New frontiers in diagnosis and therapy
2026 W. Barcellini, B. Fattizzo
Clinical Heterogeneity and Outcome of acquired PRCA: a Multicenter European Study
2026 F. Versino, M. Michel, J. Vidler, S. Payán-Pernía, R. Trikha, S.A. Gandhi, S. Gogoi, M. Wimalachandra, O. Racchi, M.T. Lupo-Stanghellini, S. Giammarco, M. Arguello Marina, M. Memoli, A. Glenthøj, G. Merati, Y.W. Wickramasinghe, A. Chitharanjan, M. Hemmer, M. Napolitano, M. Jimenez-Jambrina, F. Brioschi, A. Palma-Vallelano, T.J. Gonzalez-Lopez, C. Clissa, M. Bortolotti, G.L. Pedone, G.A. Croci, F. Passamonti, W. Barcellini, A.G. Kulasekararaj, B. Fattizzo
Thrombophilia screening in patients with autoimmune hemolytic anemia: a single-center analysis
2026 B. Fattizzo, M. Abbatista, N. Cecchi, C. Novembrino, M. Boscolo-Anzoletti, G.L. Pedone, M. Bortolotti, A. Artoni, J.A. Giannotta, F. Peyvandi, F. Passamonti, W. Barcellini, M. Capecchi
Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real‐World International Experience
2026 B. Fattizzo, E. Sambruna, Y. Miyakawa, M. Michel, C. Visco, M. Fillitz, G. Kannourakis, M.B. Greve, M. Kleemiss, J. Cid, A. Patriarca, L. Pavan, A. Dizdari, N. Maschio, A. Sau, C. Bitetti, R.M. Colombo, L. Curreli, D. Lame, U. Markovic, F. Pappagallo, G.L. Pedone, D. Rapezzi, V. Sammartano, N. Tumedei, A.G. Solimando, J. Marit, L. Fianchi, J. Khwaja, A. De Vivo, F. Lanza, F. Vianello, E.N. Oliva, C. Broome, F. Passamonti, U. Jaeger, B. Jilma, G. Moulis, W. Barcellini
Thrombosis in paroxysmal nocturnal hemoglobinuria in the complement inhibitor era: mechanisms, risk stratification, and clinical management
2026 B. Fattizzo, C.Q. Schmidt
Case Report: Refractory cold agglutinin disease with hypersplenism: efficacy of splenectomy in a patient treated with sutimlimab
2026 A. Sau, D. Onofrillo, A.C. Russo, G. Di Prinzio, A.M. Quaglietta, M. Di Ianni, B. Fattizzo
Predicting the differential diagnosis of inherited versus acquired bone marrow failure syndromes: Development of simple clinical scoring systems
2026 M. Bortolotti, B. Fattizzo, S. Stella, J. Jiang, F. Versino, C. Engelbrecht, R. Trikha, J. Large, S. Gandhi, K. Snape, D. Consonni, F. Passamonti, W. Barcellini, A.G. Kulasekararaj
Mixed Type Autoimmune Hemolytic Anemia: Clinical Severity and Treatment Patterns in a Large Observational Study
2026 F. Versino, U. Markovic, G.L. Pedone, S. Pergolizzi, F. Passamonti, W. Barcellini, A. Romano, B. Fattizzo
Sutimlimab vs B-Cell-Targeted Therapy in Cold Agglutinin Disease: Which Is the Optimal Approach?
2026 B. Fattizzo, Y. Miyakawa, C. Broome
Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study
2026 A.P. Iori, A. De Vivo, E. Di Bona, G. Caocci, F. Fioritoni, F. Ciceri, E. Beggiato, D. Rapezzi, A. Amendola, A. Figuera, C. Selleri, F. Longu, B. Fattizzo, A. Tucci, A. Cignetti, V. Amico, S. Sica, E. Metafuni, S. Raso, T.A. Urbano, L. Marano, N. Di Renzo, P. Spedini, A. Rambaldi, F. Lanza, C. Clissa, C. Danesin, M.B. Greve, S. Cabibbo, A. Ori, F. Cassanelli, F. Sottana, B. Campolo, G. Gasparri, F. Carini, W. Barcellini
Effect of obexelimab on the production of anti-RBC antibodies and cytokines in patients with warm autoimmune hemolytic anemia
2026 B. Fattizzo, A. Zaninoni, G.L. Pedone, M. Bortolotti, F. Passamonti, W. Barcellini
Incidence of infections in patients treated with rituximab for autoimmune disorders of hematological Interest or non-Hodgkin lymphoma
2026 S. Perrone, R. Tomasello, S. Raso, O. Annibali, M. Tafuri, M. Mattana, T. Soriano, D. Fanciullo, G.M. Assanto, G.L. Pedone, E. Baldacci, E. Santacroce, U. Markovic, G. Giuffrida, M.G. Ingrascì, M. Biglietto, C. Cammarata, M. Totaro, S. Ligia, B. Fattizzo, C. Santoro, S. Siragusa, M. Napolitano
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study.
2025 B. Fattizzo, A. Marchetti, A. Bosi, C. Gurnari, J. Giannotta, G. Pedone, E. Rossi, V. Carrai, A. Guido, F. Brioschi, M. Carpenedo, M. Crugnola, D. Caramazza, L. Leuzzi, M. Marchetti, G. Merati, S. Malato, F. Vianello, A. Patriarca, H. Awada, M. Bortolotti, M. Canzi, N. Bolli, M. Capecchi, F. Chen, A. Artoni, J. Maciejewski, W. Barcellini
Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencing
2025 B. Fattizzo, M.C. Da Via, F. Lazzaroni, A. Marchetti, A. Marella, A. Maeda, A.G. Solimando, L. Pettine, F. Passamonti, N. Bolli, W. Barcellini
Erythroid hypoplasia among patients with myelodysplastic neoplasms: Erythroid hypoplasia
2025 C.A. Fidanza, W. Barcellini, B. Fattizzo
Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World
2025 B. Fattizzo, C. Gurnari, S. Giammarco, A. Ricchiuti, H. Awada, M. Bortolotti, N. Galli, G.L. Pedone, F. Versino, D. Consonni, R. Trikha, S. Gandhi, S. Sica, J.P. Maciejewski, A. Kulasekararaj, W. Barcellini
Response to luspatercept can be predicted and improves overall survival in the real‐life treatment of LR‐MDS
2025 A. Consagra, L. Lanino, N.H. Al Ali, L. Aguirre, Z. Xie, O. Chan, G. Andreossi, M.G. Raddi, L. Rigodanza, A. Sanna, G. Mattiuz, E. Tofacchi, C. Amato, M. Tanturli, S. De Pourcq, A. Walker, A. Kuykendall, J. Lancet, E. Padron, D.A. Sallman, F. Restuccia, A. Perego, M. Ubezio, B. Fattizzo, M. Riva, G. Maggioni, A. Campagna, M.G. Della Porta, V. Santini, R.S. Komrokji
Real‐world evidence of pegcetacoplan in patients with paroxysmal nocturnal haemoglobinuria: A nationwide Italian study
2025 E. Metafuni, F.A. Brioschi, A. Patriarca, C. Leoni, G. Battipaglia, D. Carlino, A. Condorelli, V. Di Giacomo, S. Marktel, M.A. Marzilli, M. Miglino, E.N. Oliva, A. Sau, A. Ricco, G. Sanpaolo, A. Trolese, A.P. Iori, S. Sica, W. Barcellini, B. Fattizzo
A Case of Hodgkin Lymphoma in a Gaucher Disease Patient: Distinguishing Gaucher and Pseudo-Gaucher Cells
2025 N. Scaramellini, M. Canzi, E. Cassinerio, M. Migone De Amicis, L. Pettine, B. Fattizzo, F.G. Rossi, G. Croci, I. Motta
Progress in the use of biological therapies to treat paroxysmal nocturnal hemoglobinuria: focus on patient profiling
2025 F. Versino, B. Fattizzo